The damage done by chronic kidney disease is irreversible: once the illness has taken hold, the organ can't be healed.
Katholieke Universiteit Leuven (KU Leuven) and partners developing dual vaccine against yellow fever and rabies, supported by Horizon 2020
The RABYD-VAX consortium, led by KU Leuven, is developing a cheap and easy-to-produce vaccine against rabies AND yellow fever which allows a stable temperature during transport and storage and thus guarantees a better efficiency compared to the existing vaccines.
EMA publishes framework and action plan for closer interaction with academia
In the context of the European medicines regulatory network, the European Medicines Agency (EMA) has developed a framework and an action plan to reinforce collaboration with the academic community.
ICPerMed Action Plan for Personalised Medicine published
The International Consortium for Personalised Medicine (ICPerMed), comprising over 30 European and international members, have published a consensus Action Plan on the research and development actions needed to further advance personalised medicine.
Ebola vaccine immune responses of results obtained in EBOVAC1
EU-funded H2020 IMI research project on Ebola vaccine, EBOVAC1, induced durable immune response 1-year after vaccination.
EU support the fight against tuberculosis: Reversion of antibiotic resistance in Mycobacterium tuberculosis
The newly identified molecule SMARt-420 has shown effective results in clearance promotion of multidrug-resistance strains of Mycobacterium tuberculosis from the lungs of mice.
The work received support from the European Research Council, Marie Skłodowska-Curie actions research fellowship and the EU collaborative research grant MM4TB.
Health National Contact Points Network (Health NCP Net Project)
Estimating the risk of microcephaly following Zika virus infection
The Horizon 2020 project ZIKAlliance published a study in the Bulletin of the World Health Organization, estimating the risk of microcephaly in women infected with Zika virus during pregnancy.
The study found that the risk varies substantially across Brazil, and was affected by different factors, such as the geographical area.
23-26 April 2017, Prague, Czech Republic - 85th EAS Congress - European Atherosclerosis Society
3-5 May 2017, Amsterdam, Netherlands - EWMA 2017, 27th conference of European Wound Management Association